[Contrast Media Toxicity and Its Prevention].

Autor:	Sessa C; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Zanoli L; Nefrologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Catania, Catania (CT)., Noto G; U.O.C. Medicina e Chirurgia d'Accettazione e Urgenza, P.O. Giovanni Paolo II, Ragusa (RG)., Alessandrello I; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Galeano D; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Giglio E; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Giuffrida AE; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Distefano G; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Ficara V; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Messina RM; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Musumeci S; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Scollo V; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Zirino F; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Zuppardo C; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG)., Morale W; U.O.C. Nefrologia e Dialisi, P.O. Maggiore 'Nino Baglieri', Modica, Ragusa (RG).
Jazyk:	italština
Zdroj:	Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia [G Ital Nefrol] 2023 Oct 26; Vol. 40 (5). Date of Electronic Publication: 2023 Oct 26.
Abstrakt:	Intravenous iodinated contrast media are commonly used in clinical practice, ranging from medical imaging to interventional radiology (IR) procedures and endovascular interventions. Compared with patients with normal renal function, nephropathic patients have an increased risk of acute kidney injury (AKI). Nevertheless, this condition cannot represent a limit to diagnostics or endovascular interventions. Despite the literature of the last five years, conflicting management and approaches for nephropathic patients persist, including the use of contrast agents and treatments replacing renal functions, which are often mistakenly considered as part of preventive strategies. Though the issue has been widely discussed, specialists often cope with uncertainty in handling properly the administration of contrast media and renal counselling requests. Furthermore, there is a general difficulty in distinguishing the Post-Contrast Acute Kidney Injury (PC-AKI) from the Contrast-Associated Acute Kidney Injury (CI-AKI). The present review aims to provide an update on the issue and examine strategies to reduce the acute kidney injury risk after the administration of contrast media. These strategies include the early identification of high-risk individuals, the choice of the contrast media and the proper dosage, the suspension of nephrotoxic drugs, the follow-up of the high-risk individuals, and the early identification of AKI. (Copyright by Società Italiana di Nefrologia SIN, Rome,Italy.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu